MedPath

To study the effects of homoeopathic treatment in reduction of smokeless tobacco.

Phase 3
Conditions
Health Condition 1: F172- Nicotine dependence
Registration Number
CTRI/2023/06/054183
Lead Sponsor
oble Homoeopathic College and Research Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. New cases diagnosed on the basis of diagnostic criteria and pre diagnosed cases of smokeless tobacco.

2. Patients willing to participate in the study and giving written informed consent.

3. Only those patients will be considering into the study that have consumption of smokeless tobacco for last 1 year or more.

4. Currently and continuous uses of smokeless tobacco.

Exclusion Criteria

1. Cases with any type of oral pathology.

2. Patients with other systemic diseases.

3. Patients having mental and behaviour disorder due to psycho active substance other than tobacco.

4. Patient is already under going nicotine replacement therapy.

5. Patient already undergoing homoeopathic treatment for any chronic disease.

6. Any symptoms suggestive of any serious medical condition that may require active intervention within 6 months.

7. Pregnant women and lactating mothers.

8. Patients not giving written consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess changes in the FTND-ST through individualized homoeopathic treatment.Timepoint: Baseline, 4 weeks, 8 weeks, 12 weeks, till 6th month.
Secondary Outcome Measures
NameTimeMethod
To shortlist the commonly indicated homoeopathic medicines.Timepoint: Baseline, 4 weeks, 8 weeks, 12 weeks, till 6th month.
© Copyright 2025. All Rights Reserved by MedPath